These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 29780587)

  • 1. Development of a vancomycin dosing approach for critically ill patients receiving hybrid hemodialysis using Monte Carlo simulation.
    Lewis SJ; Mueller BA
    SAGE Open Med; 2018; 6():2050312118773257. PubMed ID: 29780587
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Monte Carlo Simulation Approach for Beta-Lactam Dosing in Critically Ill Patients Receiving Prolonged Intermittent Renal Replacement Therapy.
    Jang SM; Gharibian KN; Lewis SJ; Fissell WH; Tolwani AJ; Mueller BA
    J Clin Pharmacol; 2018 Oct; 58(10):1254-1265. PubMed ID: 29746711
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation and Development of Vancomycin Dosing Schemes to Meet New AUC/MIC Targets in Intermittent Hemodialysis Using Monte Carlo Simulation Techniques.
    Lewis SJ; Mueller BA
    J Clin Pharmacol; 2021 Feb; 61(2):211-223. PubMed ID: 32851685
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Population pharmacokinetics of vancomycin in critically ill patients receiving prolonged intermittent renal replacement therapy.
    Economou CJP; Kielstein JT; Czock D; Xie J; Field J; Richards B; Tallott M; Visser A; Koenig C; Hafer C; Schmidt JJ; Lipman J; Roberts JA
    Int J Antimicrob Agents; 2018 Aug; 52(2):151-157. PubMed ID: 29526606
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fluconazole dosing predictions in critically-ill patients receiving prolonged intermittent renal replacement therapy: a Monte Carlo simulation approach.
    Gharibian KN; Mueller BA
    Clin Nephrol; 2016 Jul; 86(7):43-50. PubMed ID: 27251341
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vancomycin and daptomycin dosing recommendations in patients receiving home hemodialysis using Monte Carlo simulation.
    Lewis SJ; Jang SM; Mueller BA
    BMC Nephrol; 2023 Sep; 24(1):270. PubMed ID: 37710245
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of Monte Carlo Simulations to Determine Optimal Carbapenem Dosing in Critically Ill Patients Receiving Prolonged Intermittent Renal Replacement Therapy.
    Lewis SJ; Kays MB; Mueller BA
    J Clin Pharmacol; 2016 Oct; 56(10):1277-87. PubMed ID: 26919659
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Initial vancomycin dosing recommendations for critically ill patients undergoing continuous venovenous hemodialysis.
    van de Vijsel LM; Walker SA; Walker SE; Yamashita S; Simor A; Hladunewich M
    Can J Hosp Pharm; 2010 May; 63(3):196-206. PubMed ID: 22478979
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Optimal vancomycin dosing regimens for critically ill patients with acute kidney injury during continuous renal replacement therapy: A Monte Carlo simulation study.
    Charoensareerat T; Chaijamorn W; Boonpeng A; Srisawat N; Pummangura C; Pattharachayakul S
    J Crit Care; 2019 Dec; 54():77-82. PubMed ID: 31394493
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vancomycin Population Pharmacokinetics in Critically Ill Adults During Sustained Low-Efficiency Dialysis.
    Kanji S; Roberts JA; Xie J; Zelenitsky S; Hiremath S; Zhang G; Watpool I; Porteous R; Patel R
    Clin Pharmacokinet; 2020 Mar; 59(3):327-334. PubMed ID: 31471789
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antibiotic Dosing for Critically Ill Adult Patients Receiving Intermittent Hemodialysis, Prolonged Intermittent Renal Replacement Therapy, and Continuous Renal Replacement Therapy: An Update.
    Hoff BM; Maker JH; Dager WE; Heintz BH
    Ann Pharmacother; 2020 Jan; 54(1):43-55. PubMed ID: 31342772
    [No Abstract]   [Full Text] [Related]  

  • 12. Pharmacokinetics of Vancomycin in Critically Ill Patients Undergoing Sustained Low-Efficiency Dialysis.
    Rider TR; Silinskie KM; Hite MS; Bress J
    Pharmacotherapy; 2020 Oct; 40(10):1036-1041. PubMed ID: 32866291
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Determination of vancomycin exposure target and individualized dosing recommendations for critically ill patients undergoing continuous renal replacement therapy.
    Wang C; Chen J; Yang B; Li S; Zhang Y; Chen L; Wang T; Dong Y
    Pharmacotherapy; 2023 Mar; 43(3):180-188. PubMed ID: 36714991
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cefepime dosing regimens in critically ill patients receiving continuous renal replacement therapy: a Monte Carlo simulation study.
    Chaijamorn W; Charoensareerat T; Srisawat N; Pattharachayakul S; Boonpeng A
    J Intensive Care; 2018; 6():61. PubMed ID: 30221005
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Optimal levofloxacin dosing regimens in critically ill patients with acute kidney injury receiving continuous renal replacement therapy.
    Rungkitwattanakul D; Chaijamorn W; Charoensareerat T; Charntrakarn P; Khamkampud O; Rattanaponpasert N; Srisawat N; Pattharachayakul S
    J Crit Care; 2021 Jun; 63():154-160. PubMed ID: 33012583
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Population pharmacokinetics and individualized dosing of vancomycin for critically ill patients receiving continuous renal replacement therapy: the role of residual diuresis.
    Yu Z; Liu J; Yu H; Zhou L; Zhu J; Liang G; Yang Y; Zheng Y; Han Y; Xu J; Han G; Yu L; Zhao Y
    Front Pharmacol; 2023; 14():1298397. PubMed ID: 38223197
    [No Abstract]   [Full Text] [Related]  

  • 17. The impact of variation in renal replacement therapy settings on piperacillin, meropenem, and vancomycin drug clearance in the critically ill: an analysis of published literature and dosing regimens*.
    Jamal JA; Udy AA; Lipman J; Roberts JA
    Crit Care Med; 2014 Jul; 42(7):1640-50. PubMed ID: 24674926
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Levetiracetam dosing in patients receiving continuous renal replacement therapy.
    Chaijamorn W; Charoensareerat T; Rungkitwattanakul D; Phunpon S; Sathienluckana T; Srisawat N; Pattharachayakul S
    Epilepsia; 2021 Sep; 62(9):2151-2158. PubMed ID: 34247386
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Exploring population pharmacokinetic models in patients treated with vancomycin during continuous venovenous haemodiafiltration (CVVHDF).
    Kirwan M; Munshi R; O'Keeffe H; Judge C; Coyle M; Deasy E; Kelly YP; Lavin PJ; Donnelly M; D'Arcy DM
    Crit Care; 2021 Dec; 25(1):443. PubMed ID: 34930430
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vancomycin dosing and monitoring for patients with end-stage renal disease receiving intermittent hemodialysis.
    Crew P; Heintz SJ; Heintz BH
    Am J Health Syst Pharm; 2015 Nov; 72(21):1856-64. PubMed ID: 26490819
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.